年龄对动脉瘤性蛛网膜下腔出血患者脑血管痉挛及迟发性脑缺血的影响
单中心回顾性研究纳入2009年1月至2023年3月治疗的925例动脉瘤性蛛网膜下腔出血患者,分析年龄与脑血管痉挛、迟发性脑缺血等结局的关系。年龄≥60岁组脑血管痉挛风险较低(aOR=0.56),但院内死亡率较高(aOR=2.24)且出院及3个月随访时改良Rankin量表评分更差;迟发性脑缺血风险无显著差异。
要点
- 年龄≥60岁与动脉瘤性蛛网膜下腔出血后脑血管痉挛风险降低相关(aOR=0.56)。
- 年龄≥60岁患者院内死亡率较高(aOR=2.24)且功能结局更差。
- 年龄对迟发性脑缺血或脑梗死风险无显著影响。
核心结论
- 患者年龄与动脉瘤性蛛网膜下腔出血后脑血管痉挛发生率呈负相关。
- 年龄≥60岁患者迟发性脑缺血发生率与年轻患者相当,但院内死亡率更高且功能结局更差。
- 作者建议重新考虑将常规筛查和依赖影像学脑血管痉挛作为动脉瘤性蛛网膜下腔出血相关并发症的主要标志物,尤其是在老年患者中。
研究设计与样本
- 单中心回顾性研究,纳入2009年1月至2023年3月治疗的925例动脉瘤性蛛网膜下腔出血患者。
- 年龄作为连续变量和分类变量(<60岁 vs ≥60岁及按十年分组)进行分析。
主要发现
- 925例患者中大多数(n=598;64.6%)年龄<60岁(46±9.1岁)。
- 年龄≥60岁组脑血管痉挛可能性较低(aOR=0.56 [0.38-0.82])。
- 年龄≥60岁组院内死亡率较高(aOR=2.24 [1.12-4.47]),出院时改良Rankin量表评分更差(aOR=2.66 [1.91-3.72]),3个月随访时改良Rankin量表评分更差(aOR=2.19 [1.44-3.32])。
- 高龄对迟发性脑缺血或脑梗死风险无显著影响。
- 随着年龄增加,院内死亡率更高(P < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association between patient age and cerebral arterial vasospasm (CVS) and delayed cerebral ischemia (DCI) risk following aneurysmal subarachnoid hemorrhage (aSAH) remains unclear. This study aims to assess the role of age on aSAH-related complications. METHODS: Single-center retrospective study comprising aSAH patients treated between January 2009 and March 2023. Age was analyzed as continuous and categorical variables (<60 yrs vs. ≥60 yrs and by decade). Outcomes of interest included radiographic CVS, DCI, cerebral infarction, in-hospital mortality, length-of-stay (LOS), ventriculoperitoneal shunt placement, and modified Rankin Scale (mRS) scores at discharge and 3-month follow-up. RESULTS: Nine hundred and twenty-five aSAH patients were included. Most (n = 598; 64.6%) were <60 yrs old (46 ± 9.1 yrs). CVS likelihood was lower in the older cohort (aOR = 0.56 [0.38-0.82]). Patients ≥60 yrs had higher mortality rates (aOR = 2.24 [1.12-4.47]) and worse mRS scores at discharge (aOR = 2.66 [1.91-3.72]) and 3-month follow-up (aOR = 2.19 [1.44-3.32]). Advanced age did not have a significant effect on DCI or cerebral infarction risk. Higher in-hospital mortality was documented with increasing age (P < 0.001). A significant interaction between CVS and age for the outcome of DCI was documented, with a stronger positive effect on poor outcomes (i.e., higher odds of DCI) among patients aged <60 years compared to those aged ≥60. CONCLUSIONS: There is an inverse relationship between patient age and CVS incidence following aSAH. Nonetheless, patients ≥60 yrs had comparable DCI rates, higher in-hospital mortality, and worse functional outcomes than their younger counterparts. Routine screening and reliance on radiographic CVS as primary marker for aSAH-related complications should be reconsidered, particularly in older patients.
引用
- Becerril-Gaitan A, Nguyen T, Liu C, et al. The Effect of Age on Cerebral Vasospasm and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2024. PMID: 38750887. doi:10.1016/j.wneu.2024.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。